Marksans Pharma Owners | StatInvestor

Health Care & Life Sciences » Pharmaceuticals | Marksans Pharma Ltd.

Marksans Pharma Ltd. | Ownership

Companies that own Marksans Pharma Ltd.

Name

Shares Held

% Shares Out

Change In Shares

% of Assets

As of Date

The Vanguard Group, Inc.

6,140,352

1.5%

07/31/2018

Dimensional Fund Advisors LP

3,224,768

0.79%

88,153

04/30/2018

Van Eck Associates Corp.

1,720,571

0.42%

09/05/2018

Norges Bank Investment Management

1,665,103

0.41%

1,660

12/31/2017

SSgA Funds Management, Inc.

1,532,557

0.37%

09/06/2018

Stanley-Laman Group Ltd.

599,100

0.15%

0.07%

06/30/2018

Columbia Management Investment Advisers LLC

329,836

0.08%

09/05/2018

TIAA-CREF Investment Management LLC

123,689

0.03%

03/31/2018

Bessemer Investment Management LLC

41,135

0.01%

41,135

04/30/2018

UBS Asset Management (UK) Ltd.

6,696

12/29/2017

About Marksans Pharma

View Profile

Address	11th Floor Grandeur Mumbai Maharashtra 400053 India
Employees	-
Website	http://www.marksanspharma.com
Updated	09/14/2018
Marksans Pharma Ltd. engages in the research, manufacture, marketing, and sale of pharmaceutical formulations. Its product portfolio spreads over major therapeutic areas such as oncology, gastroenterology, anti-diabetic, cardiovascular, pain management, and gynecology. The company was founded by Mark Saldanha on April 16, 1992 and is headquartered in Mumbai, India.